Psilocybin mushrooms, similar to LSD in their role as a serotonin 5-HT2A receptor agonist, are a classic form of psychedelic. They are presently under research for psilocybin-supported therapy for mental health disorders, such as emotional trauma related to severe depression, anxiety, cluster headaches, and migraines.
To grasp how shrooms contribute to alleviating these conditions, it’s essential to explore their metabolic process in the body. This knowledge enables researchers and consumers to understand how the active compound induces psychological and therapeutic effects. This article offers a basic overview of the pharmacology and pharmacokinetics of psilocybin.
[toc]
Key Takeaways:
- When psychedelic fungi are consumed orally, half of it is absorbed and distributed throughout the body.
- The compound in the fungi undergoes dephosphorylation through the enzyme alkaline phosphatase, mainly in the liver.
- Approximately 3.4% of the compound is expelled in its original format within 24 hours, while most of it is eliminated as a stable metabolite.
What Does Pharmacokinetics Mean?
Pharmacokinetics (PK) involves studying how the body processes substances like drugs once they are introduced into the system. It is closely linked but distinct from pharmacodynamics, which focuses on how a compound interacts with the body. PK explores four key areas: absorption, distribution, metabolism, and excretion (ADME).
Understanding these processes empowers healthcare professionals to prescribe the most effective medications with the least risk. It also allows them to customize treatments according to each patient’s unique physical constitution and lifestyle.
How Does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the main active components in certain magic mushroom species, have generated significant interest among researchers and users. Pharmacokinetics studies how psilocybin-containing mushrooms are processed by the body and aids in understanding their potential effects, whether medicinal or recreational.
These compounds are known by several terms, including “magic,” “psychedelic,” “medicinal,” or “sacred.” The fungi that bear these compounds are ingested, and The mushroom species, their origin, size, growth and drying conditions, as well as age can lead to considerable variations in their concentrations.
Even though these mushrooms naturally exist in the wild, scientists have devised techniques to artificially produce them in a laboratory. Both the natural and lab-grown mushrooms exhibit low toxicity, although minor side effects such as nausea or vomiting may be experienced.
Despite the minor side effects, the compounds present in these mushrooms possess potential therapeutic benefits owing to their safe profile and non-addictive properties. This has driven researchers to explore their application in psychotherapy, particularly as a treatment for anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the compound found in these mushrooms, is inactive in its original form, serving as a prodrug that transforms into its active state, psilocin. Enzymes such as alkaline phosphatase facilitate this conversion, which allows psilocin to be absorbed and circulated throughout the body, reaching various tissues. However, after oral ingestion, psilocybin is not detectable in the circulatory system, feces, or urine.
Absorption
Absorption refers to the process in which the compound enters the bloodstream from the point of administration. This process determines the speed and effectiveness with which the compound reaches its target, such as the plasma. Oral administration is the most common method used. Though inhalation has been tested, it proves to be less effective than oral ingestion.
The absorption process also involves the release of the compound from its dosage form during oral intake. Factors like a delay in the throat or esophagus can affect this, potentially slowing down the effects or causing irritation. Once the compound reaches the stomach, the acidic environment may start to degrade it before it enters the bloodstream.
Research on animals suggests that only about half of the orally administered psychedelics are absorbed and distributed throughout the body.
Factors Influencing Absorption
Several factors can influence the absorption process, leading to variations in the onset, intensity, and duration of effects:
- Stomach Contents: Having food in the stomach can delay the process as it slows down the onset of effects. Absorption is faster if the stomach is empty.
- Body Fat: Substances can build up in fat tissues, which might prolong their effects.
- Age: Metabolic rates and body composition often change with age.
- Zero-Order Kinetics: The substance is removed at a constant rate, irrespective of its concentration.
- First-Order Kinetics: The elimination rate is proportional to the drug’s concentration.
The phosphate group in psilocybin has high polarity. When combined with the positive charge of the amine group, this makes the molecule zwitterionic, thereby increasing its solubility in water compared to psilocin. When the phosphate group is absent, psilocin becomes more soluble in lipids, metabolically available, and is more easily absorbed in the intestines.
class=”wp-block-heading”>The Process of DistributionThe term ‘distribution’ relates to how psilocin spreads throughout the body once it enters the bloodstream. As it is lipophilic, psilocin can cross the blood-brain barrier, making its way to the central nervous system.
system.Elements like the product’s size, polarity, and protein-binding capacity, together with the individual’s physiology—such as hydration status and body makeup—significantly influence this distribution process.
The goal is to achieve an effective concentration at the target location. To be effective, the product must reach the predetermined area, as defined by the volume of distribution, and remain unbound to proteins, which allows it to actively engage with its receptor.
What Factors Can Affect Distribution?
Several factors can impact the distribution process:
Typically, effects begin to manifest between 20-40 minutes after ingestion, reaching their peak at around 80-100 minutes. The effects of magic mushrooms generally persist for 4-6 hours.
How Does the Brain Receive the Distribution?
Initial experimental studies on two species showed that the order of binding affinity is 5HT2A > 5HT1A > 5HT2B [23]. It also binds to dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, with an efficacy of about 40%. The psychedelic effects can be linked to its partial agonist activity at 5HT1A autoreceptors.
The mood-enhancing and psychotomimetic experiences could be connected to the observed correlation between increased dopamine levels and sensations of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor activity. They enhance 5HT2A agonist activity by increasing BDNF synthesis in the hippocampus, which promotes neurogenesis and reduces conditioned fear-related behaviors.
Excretion
Excretion refers to the process by which the
The human body expels substances primarily via the kidneys, but also through the lungs, skin, or gastrointestinal tract. In the kidneys, glomerular filtration or tubular secretion are the processes involved in the elimination of a naturally occurring psychedelic drug. Some reabsorption adds a layer of complexity to the elimination process.
The principal compound has a half-life of about 160 minutes, whereas psilocin’s half-life is roughly 50 minutes. Animal studies have demonstrated that this compound is mainly excreted in urine, accounting for approximately 65% within 8 hours. Even after consumption, the substance can be detected in small amounts in the bile and feces.
In humans, around 3.4% of the administered substance is expelled in its unaltered form within 24 hours. The majority is eliminated as psilocin-O-glucuronide, a stable metabolite. The compound’s stability allows for detection in urine over a prolonged period.
The two predominant methods of substance elimination are:
Most psychedelic drugs follow first-order kinetics, reaching steady-state concentrations after four to five half-lives. Complete removal also occurs after approximately four to five half-lives.
Discover Our Range of Psychedelic Mushrooms
The metabolic process can differ among various types of fungi. By shopping with reliable online providers such as Shroomyz Canada, you can avoid unintentionally ingesting poisonous mushrooms. Certain strains, like Agaric mushrooms, can cause intense and undesirable effects. Thus, it’s imperative to source your magic mushrooms from credible suppliers, instead of unpredictable street dealers or wild foraging.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Exceptionally high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Resembles a blob or | Resembles a cauliflower or brain structure | Classic cubensis look; medium-sized | Thick white stalks; caramel-tinted golden caps; visible blue bruising |
| Effects | Known as the strongest; generates intense effects | Powerful mental high; delayed start with noticeable visual enhancements | Strong visual experiences and euphoria |
Master the Use of Psilocybin Mushrooms Online
It’s crucial for medical professionals, researchers, and users to grasp the pharmacokinetics of shrooms. This knowledge allows you to make educated decisions regarding dosage and timing, reducing potential risks.
Discover your perfect psychedelic trip at Shroomyz Canada. Whether you’re after a soothing journey or a deeper exploration, our extensive product selection is tailored to meet your particular needs. Enjoy top-quality, safe, and rigorously monitored shrooms, without worries about uncertain origins or poisonous mushrooms.
Sample the finest magic mushrooms Canada has to offer and enhance your psychedelic exploration to unparalleled heights.
Frequently Asked Questions
Are there any known interactions between shrooms and other drugs?
Our products might interact with certain medications, particularly those affecting serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) usually reduce the effects, unlike non-serotonergic antidepressants. This reduced effect can last up to three months after stopping the antidepressant.
Do all psychedelics follow the same route as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to activate, and they interact with various receptors in the body. The administration method also affects the absorption of each psychedelic. While the core processes of absorption, metabolism, and distribution remain the same, the specific routes and impacts differ for each substance.
Can the mushroom’s form affect the pharmacokinetics?
Yes, the form (such as fresh, powdered, or dried mushrooms) can affect the absorption rate. For example, powdered forms may be absorbed faster than whole dried ones due to quicker dissolution.
Further Reading:
